ArminGhobadiMD
Oncology • Saint Louis, MOHematologic Oncology
Associate Professor of Medicine, Division of Medical Oncology Clinical Director, Center for Gene and Cellular Immunotherapy (CGCI) at Washington University School of Medicine in St. Louis
Dr. Ghobadi is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
4921 Parkview Pl
# Dv
Saint Louis, MO 63110Phone+1 314-454-8304Fax+1 314-454-5902
Education & Training
MD Anderson Cancer CenterBone Marrow Transplant and Cellular Therapy Fellowship, 2012 - 2013
Washington University/B-JH/SLCH ConsortiumFellowship, Hematology and Medical Oncology, 2009 - 2012
University of Texas Southwestern Medical CenterResidency, Internal Medicine, 2006 - 2009
Iran University of Medical SciencesClass of 2001
Certifications & Licensure
MO State Medical License 2011 - 2025
TX State Medical License 2012 - 2015
Clinical Trials
- Mosunetuzumab Consolidation Therapy After autoSCT in r/r Aggressive B Cell Lymphoma Start of enrollment: 2022 Dec 22
Roles: Contact, Principal Investigator
- Duvelisib Following Chimeric Antigen Receptor T-Cell Therapy Start of enrollment: 2022 Feb 28
Roles: Principal Investigator, Contact
- Tabelecleucel for Solid Organ or Allogeneic Hematopoietic Cell Transplant Participants With Epstein-Barr Virus-Associated Post-Transplant Lymphoproliferative Disease (EBV+ PTLD) After Failure of Rituximab or Rituximab and Chemotherapy Start of enrollment: 2017 Dec 29
Roles: Contact
- Join now to see all
Publications & Presentations
PubMed
- 44 citationsNCCN Guidelines® Insights: Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Version 3.2022.William G Wierda, Jennifer Brown, Jeremy S Abramson, Farrukh Awan, Syed F Bilgrami
Journal of the National Comprehensive Cancer Network. 2022-06-01 - 5 citationsAssessment of Pretreatment and Posttreatment Evolution of Neurofilament Light Chain Levels in Patients Who Develop Immune Effector Cell-Associated Neurotoxicity Syndrome.Omar H Butt, Alice Y Zhou, Paolo F Caimi, Patrick H Luckett, Julie K Wisch
JAMA Oncology. 2022-11-01 - 92 citationsFive-year follow-up of ZUMA-1 supports the curative potential of axicabtagene ciloleucel in refractory large B-cell lymphoma.Sattva S Neelapu, Caron A Jacobson, Armin Ghobadi, David B Miklos, Lazaros J Lekakis
Blood. 2023-05-11
Books/Book Chapters
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
